Studies on the anti-diabetic and hypolipidemic potentials of mangiferin (Xanthone Glucoside) in streptozotocin-induced Type 1 and Type 2 diabetic model rats.
- 12 March 2010
- journal article
- Published by Advanced Research Journals in International Journal of Advances in Pharmaceutical Sciences
- Vol. 1 (1), 75-85
- https://doi.org/10.5138/ijaps.2010.0976.1055.01009
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Mango Bioactive Compounds and Related Nutraceutical Properties—A ReviewFood Reviews International, 2009
- Maintaining a Physiological Blood Glucose Level with ‘Glucolevel’, a Combination of Four Anti-Diabetes Plants Used in the Traditional Arab Herbal MedicineEvidence-Based Complementary and Alternative Medicine, 2008
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2008
- Diabetes Treatment, Part 2: Oral Agents for Glycemic ManagementClinical Diabetes, 2007
- Global Prevalence of DiabetesDiabetes Care, 2004
- Medicinal plants of India with anti-diabetic potentialJournal of Ethnopharmacology, 2002
- A preparation and screening strategy for glycosidase inhibitorsTetrahedron, 2001
- α-Amylase Inhibitors from Roselle (Hibiscus sabdariffaLinn.) TeaBioscience, Biotechnology, and Biochemistry, 2000
- Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamideDiabetes, 1998
- Constitution of mangiferinTetrahedron, 1967